News / Blog – Page 50 – Lieff Cabraser

Thousands of U.S. communities to receive opioid recovery funds from $26 billion global settlements as soon as May 2022

Over 90% of litigating local governments have confirmed participation in the global settlements approved today by the “Big Three” drug distributors AmerisourceBergen, Cardinal Health, and McKesson, along with opioid manufacturer Johnson & Johnson Washington, D.C. (February 25, 2022) – Today, the National Prescription Opiate Litigation Plaintiffs’ Executive Committee confirmed participation of over 90% of litigating

LieffCabraser2022-02-25T18:04:51+00:00February 25th, 2022|Mass Tort, Prescription Drug Injuries, Public Good|

Anne Shaver Pens Compelling Piece for Impact Fund: Ninth Circuit Finds Discrimination To Be Concrete Injury For Purposes Of Article III Standing

The following is from a piece published by the Impact Fund written by Lieff Cabraser partner Anne B. Shaver, explaining a recent Ninth Circuit decision to reject an attempt to insulate a bank from liability for admitted citizenship discrimination on standing grounds.

LieffCabraser2023-04-19T19:24:44+00:00February 22nd, 2022|Discrimination, Firm News|

Five Lieff Cabraser Partners Named to 2022 “Lawdragon 500 Leading Lawyers in America”

On February 18, 2022, Lawdragon legal media announced its 500 Leading Lawyers in America for 2022, a list which includes Lieff Cabraser partners Kelly M. Dermody, Eric B. Fastiff, Steven E. Fineman, Annika K. Martin and Robert J. Nelson.

LieffCabraser2025-01-13T18:41:39+00:00February 19th, 2022|Firm News|

Lieff Cabraser & James J. Lee File Necrotizing Enterocolitis (NEC) Injury Lawsuit Against Abbott Laboratories Relating to Manufacture, Marketing and Sale of Similac Neosure Forumla for Infants

Lawsuit alleges willful and wrongful conduct relating to the design, development, manufacture, marketing and sale of Similac Neosure February 15, 2022, San Francisco—(BUSINESSWIRE)—Lieff Cabraser and the Legal Offices of James J. Lee announce the filing of a federal injury lawsuit against Abbott Laboratories on behalf of Darius Medley and ChaKoya Robinson, the parents of minor

admin2025-10-02T19:27:10+00:00February 15th, 2022|Infant & Child Injuries, Personal Injury|

Congress Passes Law Ending Forced Arbitration for Survivors of Sexual Assault and Harassment

The House and Senate have passed an important law to help prevent sexual harassment, called “The Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021.” It stops employers from imposing arbitration agreements on employees who have suffered sexual harassment or sexual assault by their employer. Employees now can

LieffCabraser2022-02-12T03:03:57+00:00February 11th, 2022|Consumer Fraud, Employment Law|

Happening Today: The House Will Vote on the “Ending Forced Arbitration of Sexual Assault & Sexual Harassment” Act

Congress is poised to take a huge step forward in passing a law that prohibits the use of forced arbitration clauses for sexual assault and harassment claims. Forced arbitration clauses are often included only in the fine-print of employment contracts, causing many workers to unknowingly sign away their rights and be silenced from speaking out.

LieffCabraser2022-02-07T19:41:26+00:00February 7th, 2022|Consumer Fraud|

U.S. Attorney Announces $12.9 Million Settlement With New York City Health Services Provider The Door For Submitting Fraudulent Cost Reports

Complaint in the case alleged The Door falsely inflated the number of visits to its facility on cost reports in order to fraudulently receive additional undeserved reimbursement money from the Indigent Care Pool In a press release issued today, the U.S. Attorney’s office has announced that the United States filed and settled a civil fraud

LieffCabraser2022-02-03T23:31:39+00:00February 3rd, 2022|Whistleblower Law|

Native American Tribes Reach Proposed $590 Million Opioid Settlement With Johnson & Johnson and Distributors

As reported by The New York Times (subscription) and multiple other outlets, Native American tribes have reached a $590 million proposed settlement agreement with Johnson & Johnson and three of the country’s largest opioid distributors to resolve claims over the companies’ alleged role in fueling the massive opioid addiction crisis responsible

LieffCabraser2022-02-02T01:50:45+00:00February 2nd, 2022|Firm News, Prescription Drug Injuries|

Tribes’ Claims Move Forward In Juul Vape MDL Despite Defendants’ Latest Efforts to Dismiss

As reported by Law360 (subscription), on January 28, 2022, U.S. District Judge William H. Orrick of the Northern District of California issued an order denying the bulk of the latest wave of defendant motions to dismiss two tribes’ bellwether suits in multidistrict injury and fraudulent advertising litigation against e-cigarette manufacturer Juul and its part-owner Altria. The lawsuits

LieffCabraser2022-02-01T20:08:57+00:00February 1st, 2022|Consumer Fraud, Personal Injury|

Kelly McNabb Appointed to Steering Committee of Sedona Conference Working Group 1

We are pleased to announce that Lieff Cabraser partner Kelly McNabb has been named to the Steering Committee of The Sedona Conference Working Group 1 for a three-year term commencing in January 2022. Kelly is one of six attorneys who were appointed because of their capacity for dialogue and working to reach consensus, subject-matter expertise, significant

LieffCabraser2022-01-31T21:37:32+00:00January 31st, 2022|Firm News|